Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/8/2025

Disseminated Zoster with Systemic Involvement

Investigations and Diagnosis

  • A complete skin examination is necessary to identify multidermatomal involvement (V1-V2-V3 + ipsilateral auditory canal suggests extensive dissemination) 2
  • Lumbar puncture should be performed if there is suspicion of encephalitis (altered consciousness, seizures, focal neurological deficits) 3
  • PCR VZV on CSF should be done if lumbar puncture is performed to confirm central nervous system involvement 4, 3
  • Blood cultures should be taken if there is suspicion of bacterial superinfection or sepsis 5

Treatment and Management

  • The American College of Physicians recommends acyclovir 10 mg/kg IV every 8 hours for disseminated zoster, with a minimum duration of 7-10 days, but treatment should be continued until complete clinical resolution 4, 1, 2
  • The Infectious Diseases Society of America recommends surveillance of renal function daily with adjustment of dosage if renal insufficiency occurs 1
  • The Centers for Disease Control and Prevention recommend isolation precautions until all lesions have crusted over 1

Complications and Prevention

  • Encéphalite zostérienne (zoster encephalitis) - altered consciousness, seizures, focal deficits requiring urgent lumbar puncture 4, 3
  • Syndrome de Ramsay Hunt (Ramsay Hunt syndrome) - peripheral facial paralysis with external auditory canal involvement 3, 1
  • Vascularite cérébrale (cerebral vasculitis) - ischemic or hemorrhagic stroke (can occur weeks after zoster) 3
  • Myélite transverse (transverse myelitis) - motor or sensory deficit below the lesion 3
  • Kératite (keratitis) - eye pain, photophobia, decreased visual acuity 1, 5
  • Uvéite antérieure (anterior uveitis) - red eye, pain, photophobia 1
  • Nécrose rétinienne aiguë (acute retinal necrosis) - devastating complication requiring prolonged IV treatment 1

Supportive Care and Prevention

  • Analgésiques systémiques (systemic analgesics) according to the WHO pain ladder (paracetamol, NSAIDs, opioids if necessary) 1
  • Éviter les anesthésiques topiques (avoid topical anesthetics) - minimal benefit and not recommended as primary treatment 1
  • Maintenir la peau hydratée (maintain hydrated skin) with emollients to prevent dryness and cracking 3
  • Surélévation de la zone affectée (elevate the affected area) to promote drainage of edema (particularly important for facial involvement) 3
  • Surveillance des surinfections bactériennes (monitor for bacterial superinfections) - extensive erythema, purulence, worsening pain 6, 5

Prevention of Transmission

  • Isolement contact (contact isolation) until all lesions have crusted over 1
  • Éviter contact avec personnes à risque (avoid contact with people at risk) (non-immunized pregnant women, immunocompromised individuals, newborns) 1
  • Immunoglobulines anti-VZV (anti-VZV immunoglobulin) within 96 hours for non-immunized contacts at risk 1